Healthcare and Life Science
Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signallingCompletes unique suite of rapid, scalable pain-related sodium channel assays and services to accelerate hit-to-lead and lead optimisation programmesCambridge, UK, 28 ...
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflowEnables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in can...
Speakers announced for the BioResource Scientific Conference 2025
We are excited to present our speakers for the 3rd annual NIHR BioResource Scientific Conference, taking place online on Wednesday 25 June 2025 from 9.30am to 12.30pm. ...
Patient with rare inflammatory disease of the nervous system turns to music to raise funds for Addenbrooke's
Fundraiser Ben Standing first noticed something was wrong when he started veering across pavements whilst on holiday and after an inconclusive scan halted his imminent chemo treatment, he discovered he had a rare condition called CLIPPERS... ...
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development ...
Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies
In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential of the assets As part of the agreement A...
Outpacing change in cellular connectivity
By Bruce Lancaster
Divik Seth joins Salus Wellness
We are very pleased to announce that Divik Seth has joined Salus Wellness this month. ...
Biodesix partner - Friends of Cancer Research, publishes study linking ctDNA changes to solid tumour treatment outcomes
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology ...
Mursla Bio receives FDA breakthrough device designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients EvoLiver leverages Mursla Bio’s platform based on organ-specific extracellular vesicles circulating in blood Breakthrough status provides expedited review and closer collab...